Lv1
10 积分 2023-02-16 加入
Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRAS G12D Inhibitor
1天前
已完结
TROP-2–directed antibody–drug conjugates in advanced NSCLC: A systematic review and meta-analysis of efficacy, safety, and reconstructed survival outcomes
3天前
已完结
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial
4天前
已完结
Different Diseases, Different Escapes: Trastuzumab Deruxtecan Resistance in HER2-Amplified versus HER2-Low Breast Cancer
4天前
已完结
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2 -Driven Tumors
4天前
已完结
MDM2 Amplification Enables Selective PROTAC Targeting of Tumor Cells
5天前
已完结
Pharmacogenomic Characterization of a Large Cohort of Patient-Derived Cell Lines Identifies Therapeutic Strategies for Pleural Mesothelioma
5天前
已完结
PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4 -Mutated Cancers
6天前
已完结
Intercepting endocrine resistance in ER+/HER2− metastatic breast cancer: Insights from the PADA-1 trial
19天前
已关闭
Personalized intensification of treatment for hormone-sensitive prostate cancer
20天前
已完结
皖公网安备34019202002308
